Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 12Rectal Neoplasms 9Glioblastoma 9Esophageal Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Stomach Neoplasms 7Pancreatic Neoplasms 7Lung Neoplasms 6Head and Neck Neoplasms 6Colorectal Neoplasms 5Sarcoma 4Ovarian Neoplasms 4Neoplasms 4Fallopian Tube Neoplasms 4Colonic Neoplasms 3Brain Neoplasms 3Adenocarcinoma of Lung 3Urinary Bladder Neoplasms 2Osteosarcoma 2Melanoma 2Glioma 2Carcinoma, Ovarian Epithelial 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma 2Adenocarcinoma Of Esophagus 2Xerostomia 1Wilms Tumor 1Urethral Neoplasms 1Triple Negative Breast Neoplasms 1

Interventions

Temozolomide 53Bevacizumab 33Radiotherapy 27Radiation 12Erlotinib Hydrochloride 12Radiotherapy, Intensity-Modulated 8Radiotherapy, Conformal 8Irinotecan 6Vorinostat 5Sorafenib 5Sirolimus 5temsirolimus 4Magnetic Resonance Spectroscopy 4Immunoglobulin G 4Disulfides 4Carmustine 4veliparib 3plerixafor 3carmustine, poliferprosan 20 drug combination 3Radiosurgery 3Everolimus 3Dasatinib 3Bortezomib 3vandetanib 2tandutinib 2sargramostim 2poly ICLC 2pembrolizumab 2pazopanib 2ferric pyrophosphate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Gliosarcoma × Surgical Procedures, Operative × Clear all
NCT00238303 2014-05-23

Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

National Cancer Institute (NCI)

Phase 2 Completed
103 enrolled 10 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡